Anorexia, bulimia, and the athletic triad: Evaluation and management

Current Osteoporosis Reports

Volumn 5, Issue 4, 2007, Pages 160-164

  Fenichel, Rebecca M ^a   Warren, Michelle P ^a  

^a PH 16 127 ^*

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; FOLLITROPIN; GHRELIN; LEPTIN; LUTEINIZING HORMONE; PRASTERONE; SOMATOMEDIN C;

AMENORRHEA; ANOREXIA NERVOSA; ANOVULATION; ATHLETE; BONE DENSITY; BULIMIA; CALORIC RESTRICTION; CLINICAL EVALUATION; COGNITIVE THERAPY; DUAL ENERGY X RAY ABSORPTIOMETRY; ENERGY EXPENDITURE; ESTROGEN DEFICIENCY; FRACTURE; HORMONE SUBSTITUTION; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; NUTRITIONAL DEFICIENCY; OSTEOLYSIS; OSTEOPOROSIS; PATHOPHYSIOLOGY; PATIENT IDENTIFICATION; REVIEW;

EID: 38049026779     PISSN: 15441873     EISSN: 15442241     Source Type: Journal    
DOI: 10.1007/s11914-007-0011-3     Document Type: Review

References (51)

1. Fairburn CG, Beglin SJ: Studies of the epidemiology of bulimia nervosa. Am J Psychiatry 1990, 147:401-408.
2. Hudson JI, Hiripi E, Pope HG, Jr, Kessler RC: The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication. Biol Psychiatry 2007, 61:348-358.
3. Eaton DK, Kann L, Kinchen S, et al.: Youth risk behavior surveillance-United States, 2005. MMWR Surveill Summ 2006, 55:1-108.
4. Lucas AR, Melton LJ III, Crowson CS, O'Fallon WM: Long-term fracture risk among women with anorexia nervosa: a population-based cohort study. Mayo Clin Proc 1999, 74:972-977.
5. Herzog DB, Nussbaum KM, Marmor AK: Comorbidity and outcome in eating disorders. Psychiatr Clin North Am 1996, 19:843-859.
6. Frusztajer NT, Dhuper S, Warren MP, et al.: Nutrition and the incidence of stress fractures in ballet dancers. Am J Clin Nutr 1990, 51:779-783.
7. Warren MP, Holderness CC, Lesobre V, et al.: Hypothalamic amenorrhea and hidden nutritional insults. J Soc Gynecol Investig 1994, 1:84-88.
8. Weigle DS, Duell PB, Connor WE, et al.: Effect of fasting, refeeding, and dietary fat restriction on plasma leptin levels. J Clin Endocrinol Metab 1997, 82:561-565.
9. Elimam A, Marcus C: Meal timing, fasting and glucocorticoids interplay in serum leptin concentrations and diurnal profile. Eur J Endocrinol 2002, 147:181-188.
10. Schoeller DA, Cella LK, Sinha MK, Caro JF: Entrainment of the diurnal rhythm of plasma leptin to meal timing. J Clin Invest 1997, 100:1882-1887.
11. Laughlin GA, Yen SS: Hypoleptinemia in women athletes: absence of a diurnal rhythm with amenorrhea. J Clin Endocrinol Metab 1997, 82:318-321.
12. Warren MP, Voussoughian F, Geer EB, et al.: Functional hypothalamic amenorrhea: hypoleptinemia and disordered eating. J Clin Endocrinol Metab 1999, 84:873-877.
13. Loucks AB, Thuma JR: Luteinizing hormone pulsatility is disrupted at a threshold of energy availability in regularly menstruating women. J Clin Endocrinol Metab 2003, 88:297-311.
14. Laughlin GA, Dominguez CE, Yen SS: Nutritional and endocrine-metabolic aberrations in women with functional hypothalamic amenorrhea. J Clin Endocrinol Metab 1998, 83:25-32.
15. Loucks AB, Mortola JF, Girton L, Yen SS: Alterations in the hypothalamic-pituitary-ovarian and the hypothalamic-pituitary-adrenal axes in athletic women. J Clin Endocrinol Metab 1989, 68:402-411.
16. Welt CK, Chan JL, Bullen J, et al.: Recombinant human leptin in women with hypothalamic amenorrhea. N Engl J Med 2004, 351:987-997. Although this is a small pilot study, it is the first study to administer recombinant leptin to women with hypothalamic amenorrhea, resulting in ovulation in some women and increases in markers of bone formation.
17. Schneider LF, Warren MP: Functional hypothalamic amenorrhea is associated with elevated ghrelin and disordered eating. Fertil Steril 2006, 86:1744-1749.
18. Laughlin GA, Dominguez CE, Yen SS: Nutritional and endocrine-metabolic aberrations in women with functional hypothalamic amenorrhea. J Clin Endocrinol Metab 1998, 83:25-32.
19. Loucks AB, Horvath SM: Exercise-induced stress responses of amenorrheic and eumenorrheic runners. J Clin Endocrinol Metab 1984, 59:1109-1120.
20. Grinspoon S, Thomas E, Pitts S, et al.: Prevalence and predictive factors for regional osteopenia in women with anorexia nervosa. Ann Intern Med 2000, 133:790-794.
21. Miller KK, Grinspoon SK, Ciampa J, et al.: Medical findings in outpatients with anorexia nervosa. Arch Intern Med 2005, 165:561-566.
22. Lucas AR, Melton LJ III, Crowson CS, O'Fallon WM: Long-term fracture risk among women with anorexia nervosa: a population-based cohort study. Mayo Clin Proc 1999, 74:972-977.
23. Grinspoon S, Miller K, Coyle C, et al.: Severity of osteopenia in estrogen-deficient women with anorexia nervosa and hypothalamic amenorrhea. J Clin Endocrinol Metab 1999, 84:2049-2055.
24. Grinspoon S, Baum H, Lee K, et al.: Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa. J Clin Endocrinol Metab 1996, 81:3864-3870.
25. Miller KK, Lawson EA, Mathur V, et al.: Androgens in women with anorexia nervosa and normal-weight women with hypothalamic amenorrhea. J Clin Endocrinol Metab 2007, 92:1334-1339.
26. Zanker CL: Bone metabolism in exercise associated amenorrhoea: the importance of nutrition. Br J Sports Med 1999, 33:228-229.
27. Zanker CL, Swaine IL: Bone turnover in amenorrhoeic and eumenorrhoeic women distance runners. Scand J Med Sci Sports 1998, 8:20-26.
28. Dominguez J, Goodman L, Sen GS, et al.: Treatment of anorexia nervosa is associated with increases in bone mineral density, and recovery is a biphasic process involving both nutrition and return of menses. Am J Clin Nutr 2007, 86:92-99. This important longitudinal study shows that nutritional recovery is a powerful determinant of skeletal recovery. A biphasic response is demonstrated, in which weight gain is associated with increased markers of bone formation and return of menses is associated with decreased markers of bone resorption.
29. Hotta M, Fukuda I, Sato K, et al.: The relationship between bone turnover and body weight, serum insulin-like growth factor (IGF) I, and serum IGF-binding protein levels in patients with anorexia nervosa. J Clin Endocrinol Metab 2000, 85:200-206.
30. Hadigan CM, Anderson EJ, Miller KK, et al.: Assessment of macronutrient and micronutrient intake in women with anorexia nervosa. Int J Eat Disord 2000, 28:284-292.
31. Fredericson M, Kent K: Normalization of bone density in a previously amenorrheic runner with osteoporosis. Med Sci Sports Exerc 2005, 37:1481-1486.
32. Pasco JA, Henry MJ, Kotowicz MA, et al.: Serum leptin levels are associated with bone mass in nonobese women. J Clin Endocrinol Metab 2001, 86:1884-1887.
33. Cornish J, Callon KE, Bava U, et al.: Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. J Endocrinol 2002, 175:405-415.
34. Gordeladze JO, Drevon CA, Syversen U, Reseland JE: Leptin stimulates human osteoblastic cell proliferation, de novo collagen synthesis, and mineralization: impact on differentiation markers, apoptosis, and osteoclastic signaling. J Cell Biochem 2002, 85:825-836.
35. Maor G, Rochwerger M, Segev Y, Phillip M: Leptin acts as a growth factor on the chondrocytes of skeletal growth centers. J Bone Miner Res 2002, 17:1034-1043.
36. Steppan CM, Crawford DT, Chidsey-Frink KL, et al.: Leptin is a potent stimulator of bone growth in ob/ob mice. Regul Pept 2000, 92:73-78.
37. Thomas T, Gori F, Khosla S, et al.: Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology 1999, 140:1630-1638.
38. Burguera B, Hofbauer LC, Thomas T, et al.: Leptin reduces ovariectomy-induced bone loss in rats. Endocrinology 2001, 142:3546-3553.
39. Farooqi IS, Matarese G, Lord GM, et al.: Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest 2002, 110:1093-1103.
40. Simha V, Zerwekh JE, Sakhaee K, Garg A: Effect of subcutaneous leptin replacement therapy on bone metabolism in patients with generalized lipodystrophy. J Clin Endocrinol Metab 2002, 87:4942-4945.
41. Elefteriou F, Ahn JD, Takeda S, et al: Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 2005, 434:514-520.
42. Morgan JF, Reid F, Lacey JH: The SCOFF questionnaire: assessment of a new screening tool for eating disorders. BMJ 1999, 319:1467-1468.
43. Mintz LB, O'Halloran MS: The Eating Attitudes Test: validation with DSM-IV eating disorder criteria. J Pers Assess 2000, 74:489-503.
44. Warren MP, Miller KK, Olson WH, et al.: Effects of an oral contraceptive (norgestimate/ethinyl estradiol) on bone mineral density in women with hypothalamic amenorrhea and osteopenia: an open-label extension of a double-blind, placebo-controlled study. Contraception 2005, 72:206-211.
45. Warren MP, Brooks-Gunn J, Fox RP, et al.: Persistent osteopenia in ballet dancers with amenorrhea and delayed menarche despite hormone therapy: a longitudinal study. Fertil Steril 2003, 80:398-404.
46. Drinkwater BL, Bruemner B, Chesnut CH III: Menstrual history as a determinant of current bone density in young athletes. JAMA 1990, 263:545-548.
47. Miller KK, Lee EE, Lawson EA, et al.: Determinants of skeletal loss and recovery in anorexia nervosa. J Clin Endocrinol Metab 2006, 91:2931-2937.
48. Berga SL, Marcus MD, Loucks TL, et al.: Recovery of ovarian activity in women with functional hypothalamic amenorrhea who were treated with cognitive behavior therapy. Fertil Steril 2003, 80:976-981.
49. Grinspoon S, Thomas L, Miller K, et al.: Effects of recombinant human IGF-I and oral contraceptive administration on bone density in anorexia nervosa. J Clin Endocrinol Metab 2002, 87:2883-2891.
50. Golden NH, Iglesias EA, Jacobson MS, et al.: Alendronate for the treatment of osteopenia in anorexia nervosa: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab 2005, 90:3179-3185.
51. Miller KK, Grieco KA, Mulder J, et al.: Effects of risedronate on bone density in anorexia nervosa. J Clin Endocrinol Metab 2004, 89:3903-3906.